Idenix Pharmaceuticals To Present At The Canaccord Adams Hepatitis C Conference

Main Category: Liver Disease / Hepatitis
Also Included In: Conferences;  Pharma Industry / Biotech Industry
Article Date: 04 Apr 2009 - 1:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX) announced that management will present an overview of the company's three hepatitis C programs at the Canaccord Adams Hepatitis C Conference on Tuesday, April 7 at 9:45 a.m. ET at the InterContinental The Barclay New York Hotel in New York City.

The live and archived webcasts of the presentations can be accessed under "Calendar of Events" in the Idenix Investor Center at http://www.idenix.com. Please log in approximately 5-10 minutes before the events to ensure a timely connection. The archived replays will be available on the Idenix website for two weeks following the conferences.

About Idenix

Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases. Idenix's current focus is on the treatment of infections caused by the hepatitis C virus. For further information about Idenix, please refer to http://www.idenix.com.

Idenix Pharmaceuticals, Inc.
http://www.idenix.com